Back to the list
Congress: ECR25
Poster Number: C-21337
Type: Poster: EPOS Radiologist (educational)
DOI: 10.26044/ecr2025/C-21337
Authorblock: R. E. Hinganitie, M. V. Dăbuleanu, A. M. Nechita, R. M. M. Proca, V. Ioana, D. Cuzino, A. V. Neagu; București/RO
Disclosures:
Roxana Elena Hinganitie: Nothing to disclose
Mirel Valentin Dăbuleanu: Nothing to disclose
Adina Maria Nechita: Nothing to disclose
Remus Marian Marian Proca: Nothing to disclose
Vasile Ioana: Nothing to disclose
Dragos Cuzino: Nothing to disclose
Andrei Valentin Neagu: Nothing to disclose
Keywords: Abdomen, Musculoskeletal soft tissue, Pancreas, CT, MR, Diagnostic procedure, Cancer, Metabolic disorders, Multidisciplinary cancer care
References

[1] Alfonso J. Cruz-Jentoft, Jean Pierre Baeyens, Jürgen M. Bauer, Yves Boirie, Tommy Cederholm, Francesco Landi, Finbarr C. Martin, Jean-Pierre Michel, Yves Rolland, Stéphane M. Schneider, Eva Topinková, Maurits Vandewoude, Mauro Zamboni, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age and Ageing, Volume 39, Issue 4, July 2010, Pages 412–423, https://doi.org/10.1093/ageing/afq034

[2] Alfonso J Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M Schneider, Cornel C Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Mauro Zamboni, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 , Sarcopenia: revised European consensus on definition and diagnosis, Age and Ageing, Volume 48, Issue 1, January 2019, Pages 16–31, https://doi.org/10.1093/ageing/afy169

[3] Láinez Ramos-Bossini, A. J., Gámez Martínez, A., Luengo Gómez, D., Valverde-López, F., Melguizo, C., & Prados, J. (2024). Prevalence of Sarcopenia Determined by Computed Tomography in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cancers, 16(19), 3356. https://doi.org/10.3390/cancers16193356

[4] Boutin, Robert & Yao, Lawrence & Canter, Robert & Lenchik, Leon. (2015). Sarcopenia: Current Concepts and Imaging Implications. AJR. American journal of roentgenology. 205. W1-W12. 10.2214/AJR.15.14635.

[5] Bisyri, Konstantina & Lambrou, George. (2022). The assessment of sarcopenia using magnetic resonance imaging. Journal of Research and Practice on the Musculoskeletal System. 06. 98-105. 10.22540/JRPMS-06-098.

[6] Guglielmi, Giuseppe et al. “The role of DXA in sarcopenia.” Aging clinical and experimental research vol. 28,6 (2016): 1047-1060. doi:10.1007/s40520-016-0589-3

[7] Láinez Ramos-Bossini, A. J., Gámez Martínez, A., Luengo Gómez, D., Valverde-López, F., Morillo Gil, A. J., González Flores, E., Salmerón Ruiz, Á., Jiménez Gutiérrez, P. M., Melguizo, C., & Prados, J. (2025). Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention. Cancers, 17(4), 607. https://doi.org/10.3390/cancers17040607

[8] Perrier, M., Fontaine, M., Bertin, E. et al. Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy. Eur J Clin Nutr (2025). https://doi.org/10.1038/s41430-025-01566-5

[9] Bundred, James et al. “Systematic review of sarcopenia in chronic pancreatitis: prevalence, impact on surgical outcomes, and survival.” Expert review of gastroenterology & hepatology vol. 16,7 (2022): 665-672. doi:10.1080/17474124.2022.2091544
GALLERY